Back to search

Article

Metformin Effects on Follistatin and Oxyntomodulin Levels and Its Relationship With Polycystic Ovaries Syndrome and Associated Comorbidities: Secondary Analysis of Randomized Double-blind Clinical Study.

2023-01-23

Abstract excerpt

<h4>Background: </h4> An abnormal secretion of incretins, specially Glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and oxyntomodulin (OXM), have been described in subjects with Type 2 diabetes mellitus and PCOS. OXM has important actions in the metabolism including the ability to reduce food intake and improve insulin secretion reducing the liver fat accumulation. Metformin is...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
78fde78d-6d88-5f49-a84a-851c3f013fc2
DOI
10.21203/rs.3.rs-2375448/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metformin Effects on Follistatin and Oxyntomodulin Levels and Its Relationship With Polycystic Ovaries Syndrome and Associated Comorbidities: Secondary Analysis of Randomized Double-blind Clinical Study.DOI 10.21203/rs.3.rs-2375448/v1
Select a neighboring publication to make it the new centre.